134 related articles for article (PubMed ID: 7819513)
21. Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix.
Konishi I; Fujii S; Nonogaki H; Nanbu Y; Iwai T; Mori T
Cancer; 1991 Sep; 68(6):1340-50. PubMed ID: 1651807
[TBL] [Abstract][Full Text] [Related]
22. Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions.
Zehbe I; Rätsch A; Alunni-Fabbroni M; Burzlaff A; Bakos E; Dürst M; Wilander E; Tommasino M
Oncogene; 1999 Apr; 18(13):2201-11. PubMed ID: 10327066
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
24. Relation between infection with human papilloma viruses and expression of p21 and p53 oncoproteins in patients with cancer of the uterine cervix.
Bar JK; Markowska J; Harlozińska A; Sedlaczek P; Nowak M; Roszak A
Eur J Gynaecol Oncol; 1996; 17(4):283-5. PubMed ID: 8856306
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical detection of p53 protein in cutaneous lesions from transplant recipients harbouring human papillomavirus DNA.
Pélisson I; Chardonnet Y; Euvrard S; Schmitt D
Virchows Arch; 1994; 424(6):623-30. PubMed ID: 8055156
[TBL] [Abstract][Full Text] [Related]
26. An immunohistochemical analysis of heat shock protein 70, p53, and estrogen receptor status in carcinoma of the uterine cervix.
Park CS; Joo IS; Song SY; Kim DS; Bae DS; Lee JH
Gynecol Oncol; 1999 Jul; 74(1):53-60. PubMed ID: 10385551
[TBL] [Abstract][Full Text] [Related]
27. HPV and p53 in cervical cancer.
Ngan HY; Stanley M; Liu SS; Ma HK
Genitourin Med; 1994 Jun; 70(3):167-70. PubMed ID: 8039779
[TBL] [Abstract][Full Text] [Related]
28. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
[TBL] [Abstract][Full Text] [Related]
29. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR
Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691
[TBL] [Abstract][Full Text] [Related]
30. Human papilloma virus and P53 overexpression in carcinomas of the uterine cervix, lower uterine segment and endometrium.
Hachisuga T; Matsuo N; Iwasaka T; Sugimori H; Tsuneyoshi M
Pathology; 1996 Jan; 28(1):28-31. PubMed ID: 8714266
[TBL] [Abstract][Full Text] [Related]
31. Computer-assisted analysis of p53 and PCNA expression in oral lesions infected with human papillomavirus.
Soares CP; Benatti Neto C; Fregonezi PA; Teresa DB; Santos RT; Longatto Filho A; Maeda MY
Anal Quant Cytol Histol; 2003 Feb; 25(1):19-24. PubMed ID: 12630078
[TBL] [Abstract][Full Text] [Related]
32. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.
Troncone G; Martinez JC; Palombini L; De Rosa G; Mugica C; Rodriguez JA; Zeppa P; Di Vizio D; Lucariello A; Piris MA
J Clin Pathol; 1998 Oct; 51(10):754-60. PubMed ID: 10023338
[TBL] [Abstract][Full Text] [Related]
34. p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium.
Jeffers MD; Richmond J; Farquharson M; McNicol AM
J Clin Pathol; 1994 Dec; 47(12):1073-6. PubMed ID: 7876377
[TBL] [Abstract][Full Text] [Related]
35. Characterization of human papillomavirus infection, P53 and Ki-67 expression in cervix cancer of Mozambican women.
Carrilho C; Gouveia P; Cantel M; Alberto M; Buane L; David L
Pathol Res Pract; 2003; 199(5):303-11. PubMed ID: 12908520
[TBL] [Abstract][Full Text] [Related]
36. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
Kurvinen K; Syrjänen K; Syrjänen S
J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus 16/18 expression of endocervical glandular lesions: relationship with p53 and MIB-1 Expressions.
Yoon HK; Kim YJ; Kang MS
J Korean Med Sci; 2001 Apr; 16(2):169-74. PubMed ID: 11306742
[TBL] [Abstract][Full Text] [Related]
38. Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care.
Peres AL; Paz E Silva KM; de Araújo RF; de Lima Filho JL; de Melo Júnior MR; Martins DB; de Pontes Filho NT
J Biomed Sci; 2016 May; 23(1):42. PubMed ID: 27175798
[TBL] [Abstract][Full Text] [Related]
39. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer.
Amortegui AJ; Meyer MP; Elborne VL; Amin RM
Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330
[TBL] [Abstract][Full Text] [Related]
40. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
Walts AE; Lechago J; Bose S
Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
